Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 3]

View source ↗

Summary

Phase 3 study evaluating seralutinib for pulmonary hypertension associated with interstitial lung disease is currently suspended, with updates on efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension Associated with Interstitial Lung Disease

Drugs mentioned

• Seralutinib (Seralutinib)

Snippet

Sponsor: GB002, Inc. | Conditions: Pulmonary Hypertension Associated With Interstitial Lung Disease | Phase 3 | Status: SUSPENDED